ConductScience.org, home

Paper34829313

Treatment Strategy for Dialysis Patient with Urothelial Carcinoma.

Huang YC and 4 others. Diagnostics (Basel), 2021. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Treatment Strategy for Dialysis Patient with Urothelial Carcinoma. Papers, record 34829313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34829313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment Strategy for Dialysis Patient with Urothelial Carcinoma.
PubMed
Journal
Diagnostics (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2021-11-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang YCYun-Chinghttps://orcid.org/0000-0002-5683-8406
2Liu YLYu-Liang
3Chen MFMiao-Fen
4Chen CSChih-Shou
5Wu CTChun-Te

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BMRPB51Chang Gung Medical FoundationPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134568079Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?Front Oncol2021https://conductscience.org/library/papers/34568079PubMed
222705382Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.Eur Urol2012https://conductscience.org/library/papers/22705382PubMed
316813872The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.J Urol2006https://conductscience.org/library/papers/16813872PubMed
419933687Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.Jpn J Clin Oncol2010https://conductscience.org/library/papers/19933687PubMed
529139021Perioperative Complications and Mortality in Patients with Urothelial Carcinoma and End-Stage Renal Disease Undergoing One-Stage Complete Urinary Tract Extirpation.Ann Surg Oncol2018https://conductscience.org/library/papers/29139021PubMed
621272136High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease.Nephrology (Carlton)2011https://conductscience.org/library/papers/21272136PubMed
711025695Upper tract urothelial neoplasms: incidence and survival during the last 2 decades.J Urol2000https://conductscience.org/library/papers/11025695PubMed
822917985ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.Eur Urol2013https://conductscience.org/library/papers/22917985PubMed
918675501Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.Eur Urol2009https://conductscience.org/library/papers/18675501PubMed
1025662835Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.Am J Kidney Dis2015https://conductscience.org/library/papers/25662835PubMed
1126657777Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients.Sci Rep2015https://conductscience.org/library/papers/26657777PubMed
1228161840Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer.Int Urol Nephrol2017https://conductscience.org/library/papers/28161840PubMed
1322335874Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes.J Urol2012https://conductscience.org/library/papers/22335874PubMed
1428456635Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.J Urol2017https://conductscience.org/library/papers/28456635PubMed
1516022085Characterizing comorbidity in dialysis patients: principles of measurement and applications in risk adjustment and patient care.Perit Dial Int2005https://conductscience.org/library/papers/16022085PubMed
1631704083US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.Am J Kidney Dis2020https://conductscience.org/library/papers/31704083PubMed
1714665859Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma.J Urol2004https://conductscience.org/library/papers/14665859PubMed
1832550634Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single-center experience with 10-year outcomes.Minerva Urol Nefrol2020https://conductscience.org/library/papers/32550634PubMed
1920082919Excerpts from the US Renal Data System 2009 Annual Data Report.Am J Kidney Dis2010https://conductscience.org/library/papers/20082919PubMed
2025170766Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.PLoS One2014https://conductscience.org/library/papers/25170766PubMed

See all 40 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41190277Progression of hydronephrosis in end-stage renal disease as a potential indicator of underlying upper urinary tract tumors: a report of a rare case.Ther Adv Urol2025https://conductscience.org/library/papers/41190277PubMed
39090146No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy.Sci Rep2024https://conductscience.org/library/papers/39090146PubMed
37232843One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report.Curr Oncol2023https://conductscience.org/library/papers/37232843PubMed
36980748Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma.Cancers (Basel)2023https://conductscience.org/library/papers/36980748PubMed
35884573Perioperative Complications and Oncologic Outcomes after Radical Cystectomy in End-Stage Renal Disease Patients with Bladder Cancer Obtained Using a Standardized Reporting System.Cancers (Basel)2022https://conductscience.org/library/papers/35884573PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APC324PubTator's text mininghttps://conductscience.org/library/genes/324

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34829313

GET https://conductscience.org/api/papers/v1/34829313/references?page=2